The GLP is committed to full transparency. Download and review our 2019 Annual Report

Bayer releases 107 Roundup safety studies as glyphosate-cancer legal battle continues

| April 9, 2019
bayer ag logo pd v z a par a l
Credit: The Hennessy Group
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

With recent legal battles, Bayer [has released]….all 107 Bayer-owned glyphosate safety study reports that were submitted to the European Food Safety Authority as part of the substance authorization process in the European Union are now accessible on Bayer’s dedicated transparency platform.

“Transparency is a catalyst for trust, so more transparency is a good thing for consumers, policymakers, and businesses. As an innovation company, safety is our top priority and we are completely committed to doing everything we can to ensure that our products are safe for people and the environment,” said Liam Condon, member of the Board of Management of Bayer AG and president of the Crop Science Division.  “….We embrace the opportunity to engage in dialogue so we can build more trust in sound science.”

Related article:  Seralini rat study on toxicity of GM crops republished

This new addition to the Bayer Transparency platform follows last December’s publication of more than 300 glyphosate safety study summaries submitted under the EU substance authorization process for plant protection products. Access has now been enabled to all the related in-depth glyphosate safety studies to which Bayer wholly owns the rights. Due to legal restrictions, Bayer cannot release the glyphosate studies….owned by third parties.

Read full, original article: Bayer releases glyphosate safety reports for transparency

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend